November 27, 2021
Psyence Group Inc. files Q2 Unaudited Condensed Consolidated Interim Financial Statements and MD&A
TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a…
Pharmaceuticals, Biotechnology and Life Sciences
Author: GlobeNewswire
November 27, 2021
Akero Therapeutics to Present at the Evercore ISI 4th Annual HealthCONx Virtual Conference
SOUTH SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients…
November 27, 2021
“Olainfarm” unaudited consolidated financial statement of the 9-month interim period of 2021
“Olainfarm” unaudited consolidated financial statement of the 9-month interim period of 2021 In the nine months of 2021, the Group’s…
November 27, 2021
AnPac Bio Reports Nine Months Ended September 30, 2021, Same Period Achieved Record Revenue Increased By 55.3% While Non-GAAP Net Loss Reduced by 6.8%
PHILADELPHIA, Nov. 26, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC),…
November 27, 2021
Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the “Life Sciences” Category
MONTREAL, Nov. 26, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused…
November 27, 2021
Psyence Group Invited as First Psychedelic Company to present at the 15th-Annual Global Wellness Summit
TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a…
November 27, 2021
NRx Pharmaceuticals Notes New Data on BriLife® COVID-19 Vaccine Effectiveness Against Delta Variant Posted by Israel Institute for Biological Research
Analysis of Blood Samples from Patients who Responded to the BriLife® Vaccine During Phase 2 Trial Suggests that the Same…
November 27, 2021
QuantuMDx confirm its diagnostic tests remain able to detect all known variants of COVID-19 including the new variant from South Africa, B.1.1.529
NEWCASTLE UPON TYNE, UK, 26 NOVEMBER 2021. QuantuMDx Group Limited (“QuantuMDx”), today confirms that both its SARS-CoV-2 assays for open…
November 27, 2021
Ocugen, Inc. Provides an Update on its Investigational New Drug Application with U.S. FDA to Initiate a Phase 3 Clinical Trial Evaluating COVID-19 Vaccine Candidate COVAXIN™ (BBV152)
MALVERN, Pa., Nov. 26, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and…
November 27, 2021
MediPharm Labs Completes Medical Cannabis Export to Barbados
Patient based delivery of medical cannabis executed with approval from both Barbados and Canadian Health Authorities.This marks the fourth new…